Skip to content

5008S CorDiax

HighVolumeHDF as easy as HD

  • AutoSub plus — Automatically maximizing substitution volume for HighVolumeHDF
  • Venous Access Monitoring (VAM) — Optimized monitoring of the venous path
  • Easy handling
  • Efficient and sustainable

DISCLAIMER

Not all products and services are cleared or available for sale in all EU countries. Check your country web site for details. 

HighVolumeHDF as standard

With the new AutoSub plus function of the 5008S CorDiax HighVolumeHDF becomes as simple and reliable as HD without any additional need for user interaction.

5008S CorDiax

Opening a world of possibilities

5008S CorDiax enables HighVolumeHDF as a standard in dialysis thanks to AutoSub plus for automatically maximized substitution volumes and the Venous Access Monitor (VAM) for increased probability of early detection of needle dislodgement.

HighVolumeHDF therapy

HighVolumeHDF – The standard in cardioprotective hemodialysis

In order to achieve the full benefits of HDF therapy large convective volumes in post-dilution mode are required. In the past many users were concerned that these high volumes may lead to excessive hemoconcentration and subsequently high transmembrane pressures if the treatment settings are not continuously monitored and adjusted.

AutoSub plus

Automatically maximizing substitution volume for HighVolumeHDF

The innovative AutoSub plus system is much more than just another automatic pressure control:
Very precise information on the conditions in the dialyzer is available - not just across the membrane but also along the blood flow pathway
Several checks per minute enable the continuous optimization of the substitution rates
The system is automatically activated at the start of treatment
AutoSub plus supports the nephrologist in establishing HighVolumeHDF as standard therapy.

Insight and continuity make the difference

While other systems check and adjust the transmembrane pressure (TMP) in defined time intervals, AutoSub plus measures and evaluates the conditions directly inside the filter several times per minute. The innovative technology behind it is based on a dynamic signal analysis of pressure pulses. As a result, substitution volumes can be maximized individually for every patient without any user interaction.

Safety creates confidence

In particular during HighVolumeHDF where high blood flows are aspired for, monitoring of the venous access is essential as a blood loss would become critical within a very short time. The 5008S CorDiax offer as standard in all machines a sophisticated safety feature to minimize the risk of external blood loss:

Venous Access Monitoring (VAM) — Optimized monitoring of the venous path

VAM is a unique and intelligent safety feature. It enables dynamic and highly-sensitive monitoring of the venous pressure by combining arterial and venous pressure signals with an adaptive algorithm.  In this way, VAM is designed to indicate sudden, small drops in venous pressure of approximately 15 mmHg, even when the venous pressure does not exceed the lower alarm limit.   VAM has been developed to support the health-care professionals in early detection of venous needle dislodgement. Still, the user remains responsible for patient safety at all times during treatment. VAM also includes an alarm management system: an alarm is activated if the monitored signals show exceptional or abnormal variations to the previous pressure profile.

If an alarm is emitted, the blood pump is stopped immediately and the venous clamp is closed. This aims to give the nursing staff more time to react appropriately to critical pressure changes.

Easy handling

ONLINEplus – Reducing workload, increasing usage

Historically, the required amounts of substitution fluid had to be provided in infusion bags. This added to the workload of the nursing staff and deterred dialysis-centers from using HDF. In order to give more patients access to the benefits of HDF, we have developed a dialysis system, which prepares the substitution fluid directly at the bedside – The ONLINEplus system. Based on the highly reliable two stage filtration process ONLINEplus facilitates the online production of sterile and nonpyrogenic substitution fluid very cost-efficiently. Online hemodiafiltration was born.

Blood lines

Our innovative blood lines are developed based on the idea that HighVolumeHDF shall be as easy and safe to handle as HD. With a standard setup of a 5008S CorDiax you can already perform HighVolumeHDF.

Efficient and sustainable

It is not only the advanced treatment options that makes the 5008S CorDiax series unique, but also its eco-friendliness: Fresenius Medical Care supports the sensible and sustainable use of resources by saving dialysate, water and energy. This in turn leads to significant cost savings.

  • ONLINEplus technology for production of sterile, endotoxin-free and  bicarbonate-buffered electrolyte solutions1
    • Extensive amounts of substitution fluid for HDF available
    • No more need for ready-made rinse solutions: priming, reinfusion and bolus with ONLINE fluid in all treatment modes (also in HD)2
  • AutoFlow automatically adjusts the dialysate flow rate to the effective blood flow rate during treatment
    • Substantial saving of water, waste water, concentrates and energy, leading to significant cost reductions
    • Automatic selection of AutoFlow factor based on treatment mode, always accomplishing an optimal ratio between economic considerations and treatment quality
  • EcoFlow for minimized dialysate and energy consumption during preparation and after reinfusion while avoiding bacterial growth
Related content

1 In accordance with ISO 23500-5 and ISO 11663:2009.

2 Safety advice: It is recommended that you stock sodium chloride in case it might be required.

Contact Us

EN Master form container

Request a sales meet, demo or brochure by using this contact form

The information you provide will only be used to answer your query. For more information on how we process your Personal Data please read our privacy policy

This contact form is not intended to submit an adverse event related to medicinal products. To report an adverse event, please contact us at corporate-drug-safety(at)freseniusmedicalcare.com.

Contact

captcha